Bupropion interferes with the image diagnosis of Parkinson's disease

Chieh-Hsin Lin,1–3 Hsien-Yuan Lane2,4 1Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan, 2Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, 3Center for General Education, Che...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lin CH, Lane HY
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/b8c31871236b4ae1b44e6396ed651d7b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b8c31871236b4ae1b44e6396ed651d7b
record_format dspace
spelling oai:doaj.org-article:b8c31871236b4ae1b44e6396ed651d7b2021-12-02T07:19:59ZBupropion interferes with the image diagnosis of Parkinson's disease1178-2021https://doaj.org/article/b8c31871236b4ae1b44e6396ed651d7b2017-10-01T00:00:00Zhttps://www.dovepress.com/bupropion-interferes-with-the-image-diagnosis-of-parkinson39s-disease-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Chieh-Hsin Lin,1–3 Hsien-Yuan Lane2,4 1Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan, 2Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, 3Center for General Education, Cheng Shiu University, Kaohsiung, Taiwan, 4Department of Psychiatry, China Medical University Hospital, Taichung, Taiwan Abstract: Major depressive disorder (MDD) and Parkinson’s disease (PD) share symptoms such as tremor. Bupropion, a norepinephrine–dopamine reuptake inhibitor, shows weak dopamine transporter (DAT) occupancy. We report here on a patient with MDD whose hand tremors might have been misdiagnosed as PD by single-photon emission computed tomography (SPECT) under bupropion use. A 66-year-old male patient with MDD had been receiving bupropion 150 mg per day for 6 months. His mood symptoms improved partially with bupropion treatment, however, hand tremors persisted. The neurological examination revealed bilateral hand tremors without other typical signs for PD. The SPECT using Tc-99m TRODAT-1 revealed decreased DAT binding capacity in bilateral striata. Under the impression of atypical PD, the patient was advised to take anti-Parkinson’s drug. Bupropion was discontinued for 14 days to confirm the test. The follow-up SPECT after 14 days found improvement for the uptake ratio of striata. From then onward, the anti-Parkinson’s drug was not used due to the lack of typical sign(s) for PD. The patient’s mental and physical status remained stable without worsening of hand tremors during follow-up. Tc-99m TRODAT-1 SPECT is helpful for the evaluation of DAT and the diagnosis of PD. However, the interpretation of the SPECT image might be biased by the use of certain drugs such as bupropion for its binding to DAT. Bupropion may decrease the Tc-99m TRODAT-1 binding to DAT. The effect of drugs on DAT should be carefully assessed while interpreting the Tc-99m TRODAT-1 image. Our findings suggest that all drugs that may alter DAT occupancy should be listed as the reference for Tc-99m TRODAT-1 image reading. Keywords: bupropion, dopamine transporter, single-photon emission computed tomography, Parkinson’s disease, Tc-99m TRODAT-1Lin CHLane HYDove Medical Pressarticlebupropiondopamine transportersingle-photon emission computed tomographyParkinson diseaseTc-99m TRODAT-1Neurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 13, Pp 2637-2639 (2017)
institution DOAJ
collection DOAJ
language EN
topic bupropion
dopamine transporter
single-photon emission computed tomography
Parkinson disease
Tc-99m TRODAT-1
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle bupropion
dopamine transporter
single-photon emission computed tomography
Parkinson disease
Tc-99m TRODAT-1
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Lin CH
Lane HY
Bupropion interferes with the image diagnosis of Parkinson's disease
description Chieh-Hsin Lin,1–3 Hsien-Yuan Lane2,4 1Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan, 2Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, 3Center for General Education, Cheng Shiu University, Kaohsiung, Taiwan, 4Department of Psychiatry, China Medical University Hospital, Taichung, Taiwan Abstract: Major depressive disorder (MDD) and Parkinson’s disease (PD) share symptoms such as tremor. Bupropion, a norepinephrine–dopamine reuptake inhibitor, shows weak dopamine transporter (DAT) occupancy. We report here on a patient with MDD whose hand tremors might have been misdiagnosed as PD by single-photon emission computed tomography (SPECT) under bupropion use. A 66-year-old male patient with MDD had been receiving bupropion 150 mg per day for 6 months. His mood symptoms improved partially with bupropion treatment, however, hand tremors persisted. The neurological examination revealed bilateral hand tremors without other typical signs for PD. The SPECT using Tc-99m TRODAT-1 revealed decreased DAT binding capacity in bilateral striata. Under the impression of atypical PD, the patient was advised to take anti-Parkinson’s drug. Bupropion was discontinued for 14 days to confirm the test. The follow-up SPECT after 14 days found improvement for the uptake ratio of striata. From then onward, the anti-Parkinson’s drug was not used due to the lack of typical sign(s) for PD. The patient’s mental and physical status remained stable without worsening of hand tremors during follow-up. Tc-99m TRODAT-1 SPECT is helpful for the evaluation of DAT and the diagnosis of PD. However, the interpretation of the SPECT image might be biased by the use of certain drugs such as bupropion for its binding to DAT. Bupropion may decrease the Tc-99m TRODAT-1 binding to DAT. The effect of drugs on DAT should be carefully assessed while interpreting the Tc-99m TRODAT-1 image. Our findings suggest that all drugs that may alter DAT occupancy should be listed as the reference for Tc-99m TRODAT-1 image reading. Keywords: bupropion, dopamine transporter, single-photon emission computed tomography, Parkinson’s disease, Tc-99m TRODAT-1
format article
author Lin CH
Lane HY
author_facet Lin CH
Lane HY
author_sort Lin CH
title Bupropion interferes with the image diagnosis of Parkinson's disease
title_short Bupropion interferes with the image diagnosis of Parkinson's disease
title_full Bupropion interferes with the image diagnosis of Parkinson's disease
title_fullStr Bupropion interferes with the image diagnosis of Parkinson's disease
title_full_unstemmed Bupropion interferes with the image diagnosis of Parkinson's disease
title_sort bupropion interferes with the image diagnosis of parkinson's disease
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/b8c31871236b4ae1b44e6396ed651d7b
work_keys_str_mv AT linch bupropioninterfereswiththeimagediagnosisofparkinson39sdisease
AT lanehy bupropioninterfereswiththeimagediagnosisofparkinson39sdisease
_version_ 1718399475304628224